Nektar shares plunge after pain drug study

by admin on September 26, 2013

Nektar Therapeutics shares sank in extended trading Thursday after the pharmaceutical maker said that a recent mid-stage study of its pain drug failed to meet its goal. The San Francisco company's drug, …

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: